NEXT
Sign in to follow
Search Results

0 results for ''Lerner David Littenberg''

You can use to get even better search results
August 22, 2005 | New Jersey Law Journal

Medpointe Health Care, Inc. v. Hi-Tech Pharmacal Co., Inc., etc.

The part of defendants' proposed amended pleadings regarding plaintiff's nondisclosure of the prior judicial ruling on an earlier patent fails to state a claim for patent misuse or unclean hands because the earlier patent concerns a product different from that addressed by the present patent; moreover, plaintiff's alleged misconduct did not broaden the patent's physical or temporal scope; the allegations of patent misuse and unclean hands are therefore futile and the motions for leave to amend are denied.
14 minute read
July 06, 2005 | Law.com

Deals on Wheels

Corporate dealmaking has become the hottest niche at New Jersey's biggest law firms and is fueling the competition for laterals. In a recent survey, almost everyone put corporate transactional business atop the lists of growth fields, with some observers citing the state's health sciences companies as the source of much of the work. "That type of work is microcyclical," says Reed Smith's Steven Picco. "It flashes hot and then goes away, and right now it's hot."
7 minute read
November 01, 2007 | Corporate Counsel

Who Protects: The Companies

24 minute read
February 05, 2004 | Law.com

Are Federal Appellate Practitioners Free at Last?

A major salvo has been fired in a long-simmering struggle for free expression. In a November edition of West's Supreme Court Reporter were buried proposed rule changes for the federal courts, including the Federal Rules of Appellate Procedure. Among the proposals: lawyers practicing in those courts could not be prohibited from citing to an appellate court the prior decisions of that court that are not formally published.
10 minute read
September 18, 2006 | National Law Journal

The NLJ Client List | Who Represents Corporate America

57 minute read
April 11, 2013 | New Jersey Law Journal

Structure Has Little To Do with Structural Obviousness

A recently denied petition for certiorari from a case originating in N.J. questioned the current method for determining the patentability of molecules. Obviousness had previously been found where there was a high degree of structural similarity between a new molecule and a prior art molecule. Now, courts have required a reason, apart from structure, to even select a particular molecule, a so-called "lead compound," as the starting point of the obviousness analysis.
9 minute read
September 12, 2005 | National Law Journal

The NLJ Client List�Who Represents Corporate America

The National Law Journal and Corporate Counsel magazine surveyed the legal departments of the Fortune 250 companies and reported on which law firms they use most often.
78 minute read
September 26, 2013 | New Jersey Law Journal

Do the Courts Really Understand DNA?

Ideally, judges and laywers would understand not only the IP laws they are applying, but also the science that is protected by those laws. But is that possible in this time of rapidly changing technology?
10 minute read
September 26, 2011 | New Jersey Law Journal

Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)

Notice to the bar.
483 minute read
September 24, 2010 | New Jersey Law Journal

2010 Ineligible List

Attorney Ineligibility Order Pursuant to Rule 1:28-2(a)
452 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • CFIUS Compliance: Your Organization's Growth and Investment Strategy May Be a Matter of National Security

    Brought to you by HaystackID

    Download Now

  • Document Review Challenges: Strategies for Law Firm Litigation Professionals in 2024

    Brought to you by Integreon

    Download Now

  • From Burnout to Breakthrough: How Technology Enhances Legal Wellness

    Brought to you by Nuix

    Download Now

  • The 2024 Benchmark of Ethical Culture Report

    Brought to you by LRN

    Download Now